News Center

Discover all of the trending news of the Ipsen Group


157 results

Oncology

Ipsen in Oncology: Unlocking the power of data

31 October 2019

[caption id="attachment_6816" align="alignleft" width="150"] Bartek Bednarz, SVP Global Product and Portfolio Strategy, Ipsen[/caption] We’re excited…

Neuroscience

World Stroke Day: When it comes to stroke, Don’t Be the One.

24 October 2019

World Stroke Day is on Tuesday, 29 October, and the World Stroke Organization will…

Financial information

Ipsen – 2019 Q3 results – October 24, 2019 at 2:30pm CEST

24 October 2019

To register to the webcast, please click here. Ipsen will hold a conference call Thursday,…

Patient

Ipsen’s first clinical trial lay summary developed with pati...

18 October 2019

Here at Ipsen, we are committed to working with patients, for patients. As part of…

Rare diseases

Ipsen and Blueprint enter exclusive agreement in FOP

16 October 2019

Today, Ipsen announced it has entered into an exclusive, worldwide agreement with Blueprint Medicines…

Oncology

Rethink liver cancer: Increase your understanding this Liver...

01 October 2019

This Liver Cancer Awareness Month, we challenge you to rethink liver cancer. Learn more about…

Oncology

Ipsen in Oncology: For us, it’s personal

27 September 2019

[caption id="attachment_6649" align="aligncenter" width="589"] Bartek BEDNARZ, SVP Global Product and Portfolio Strategy, IPSEN[/caption] At…

Innovation

How data analysis can outpace the lab to answer clinically p...

20 September 2019

[caption id="attachment_5663" align="alignnone" width="226"] Ulf Staginnus, SVP, Head Global Market Access & Pricing at Ipsen[/caption]…

Innovation

#WeWontRest in using digital innovation to transform patient...

16 September 2019

[caption id="" align="aligncenter" width="262"] Harout Semerjian, EVP, Chief Commercial Officer, Ipsen[/caption] The European Federation…

Financial information

Ipsen will hold a conference call Thursday, 25 July 2018 at ...

18 July 2019

Participants should dial in to the call approximately five to ten minutes prior to its…

Patient

COSMIC-021 trial

15 July 2019

As part of Ipsen’s ongoing commitment to improve outcomes for patients with high unmet medical…

Innovation

Fulfilling our Bold Promise Through External Innovation

24 June 2019

Ivana Magovčević-Liebisch Ph.D., J.D. Executive Vice-President, Chief Business Officer It has just been…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023